Gene Editing Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Growing Applications of Genomics
   3. Market Restraints
      1. Ethical and Regulatory Challenges
      2. Technical Limitations and Off-Target Effects
   4. Market Opportunity
      1. Expanding Pipeline for Gene Therapy
   5. Market Trends
      1. Expansion of Gene Editing Applications Beyond Human Health
5. MARKET SEGMENTATION
   1. By Product & Services
      1. Reagents & Consumables
      2. Software & Systems
      3. Services
   2. By Technology
      1. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
      2. Transcription Activator-Like Effector Nuclease (TALEN)
      3. Zinc Finger Nuclease (ZFN)
      4. Antisense
      5. Other Technologies
   3. By Application
      1. Cell Line Engineering
      2. Genetic Engineering
      3. Drug Discovery & Development
      4. Other Applications
   4. By End-user
      1. Pharmaceutical and Biotechnology Companies
      2. Academic and Research Institutes
      3. Other End Users
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Agilent Technologies
      2. Bluebird Bio
      3. Bean Therapeutics
      4. Beren Therapeutics
      5. Creative Biogene
      6. Horizon Discovery Group plc.
      7. Integrated DNA Technologies
      8. Intellia Therapeutics
      9. Lonza
      10. Synthego
      11. Thermo Fisher-Scientific
      12. Tecan Life-Sciences
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Gene Editing market?

The global market of Gene Editing is projected to reach USD 20.23Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Gene Editing market?

The global Gene Editing market has an estimated annual growth rate of 15.0%.

Q.3. What are the recent trends of Gene Editing market?

Expansion of gene editing applications beyond human healthis one of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in Gene Editing?

The major companies profiled in this report include Agilent Technologies, Bluebird Bio, Bean Therapeutics, Beren Therapeutics, Creative Biogene, Horizon Discovery Group plc., Integrated DNA Technologies, Intellia Therapeutics, Lonza, Synthego, Thermo Fisher-Scientific, Tecan Life-Sciences, among others.  

Q.5. Which is the largest regional market in the Gene Editing?

North America is the largest regional market for Gene Editing.